Please note that the copy function is not enabled for this field.
If you wish to
modify
existing outcomes, please copy and paste the current outcome text into the Update field.
LOGIN
CREATE ACCOUNT
LOGIN
CREATE ACCOUNT
MY TRIALS
REGISTER TRIAL
FAQs
HINTS AND TIPS
DEFINITIONS
Trial Review
The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this
information for consumers
Download to PDF
Trial details imported from ClinicalTrials.gov
For full trial details, please see the original record at
https://clinicaltrials.gov/study/NCT01480479
Registration number
NCT01480479
Ethics application status
Date submitted
21/11/2011
Date registered
29/11/2011
Date last updated
16/01/2018
Titles & IDs
Public title
Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
Query!
Scientific title
An International, Randomized, Double-Blind, Controlled Study of Rindopepimut/GM-CSF With Adjuvant Temozolomide in Patients With Newly Diagnosed, Surgically Resected, EGFRvIII-positive Glioblastoma
Query!
Secondary ID [1]
0
0
CDX110-04
Query!
Universal Trial Number (UTN)
Query!
Trial acronym
ACT IV
Query!
Linked study record
Query!
Health condition
Health condition(s) or problem(s) studied:
Glioblastoma
0
0
Query!
Small Cell Glioblastoma
0
0
Query!
Giant Cell Glioblastoma
0
0
Query!
Gliosarcoma
0
0
Query!
Glioblastoma With Oligodendroglial Component
0
0
Query!
Condition category
Condition code
Cancer
0
0
0
0
Query!
Brain
Query!
Intervention/exposure
Study type
Interventional
Query!
Description of intervention(s) / exposure
Treatment: Drugs - Rindopepimut (CDX-110) with GM-CSF
Treatment: Drugs - Temozolomide
Treatment: Drugs - KLH
Experimental: Rindopepimut/GM-CSF plus Temozolomide -
Active comparator: KLH plus Temozolomide -
Treatment: Drugs: Rindopepimut (CDX-110) with GM-CSF
Two intradermal injections two weeks apart, followed by monthly injections until tumor progression or intolerance.
Each dose will be 0.8 mL containing approximately 500 mcg CDX-110 and 150 mcg GM CSF.
Treatment: Drugs: Temozolomide
150 to 200 mg/m2 for 5 days during each 28-day cycle for a minimum of six cycles or a maximum of 12 cycles, or until intolerance or progression.
Treatment: Drugs: KLH
Two intradermal injections two weeks apart, followed by monthly injections until tumor progression or intolerance. Each dose will be 0.8mL containing approximately 100mcg of KLH.
Query!
Intervention code [1]
0
0
Treatment: Drugs
Query!
Comparator / control treatment
Query!
Control group
Query!
Outcomes
Primary outcome [1]
0
0
Overall Survival
Query!
Assessment method [1]
0
0
The primary efficacy endpoint of Overall Survival is defined as the number of months from randomization to the date of death (whatever the cause), and will be censored for patients who remain alive at completion of the study for patients with a gross total resection (\~n=374). The overall survival of patients will be monitored and compared between the two study arms until the end of the study.
Query!
Timepoint [1]
0
0
During treatment and every three months from end of treatment through end of study or approximately up to 5 years.
Query!
Secondary outcome [1]
0
0
Progression-free survival
Query!
Assessment method [1]
0
0
Compare progression-free survival between the two treatment arms
Query!
Timepoint [1]
0
0
Every 12 weeks from Day 1 through progression or initiation of other anti-cancer therapy
Query!
Secondary outcome [2]
0
0
Safety and Tolerability
Query!
Assessment method [2]
0
0
Safety and tolerability will be measured by comparing the two arms in regards to vital sign measurement, physical and neurological examination, adverse events reporting, ECOG performance status, and EORTC core Quality of Life Questionnaire
Query!
Timepoint [2]
0
0
Until day 28 of follow up
Query!
Eligibility
Key inclusion criteria
Inclusion Criteria-
Among other criteria, patients must meet the following conditions to be eligible for the study:
1. Adult patients, = 18 years old
2. Newly diagnosed glioblastoma
3. Attempted surgical resection followed by conventional chemoradiation
4. Documented EGFRvIII positive tumor status by a Sponsor designated laboratory
5. No evidence of progressive disease from the post-operative period to the post-chemoradiation period
6. Candidate for, and agrees to receive, adjuvant (maintenance) temozolomide therapy
7. Systemic corticosteroid therapy at =2 mg of dexamethasone or equivalent per day for at least 3 days prior to randomization
8. WHO-ECOG Performance Status = 2
9. Patients of childbearing/reproductive potential will be instructed to use birth control as defined by your doctor.
Query!
Minimum age
18
Years
Query!
Query!
Maximum age
No limit
Query!
Query!
Sex
Both males and females
Query!
Can healthy volunteers participate?
No
Query!
Key exclusion criteria
Exclusion Criteria-
Among other criteria, patients who meet the following conditions are NOT eligible for the study:
1. Stereotactic biopsy only (without further surgical resection)
2. Presence of diffuse leptomeningeal disease, gliomatosis cerebri, or infratentorial disease.
3. History, presence, or suspicion of metastatic disease
4. Patients who have received any additional treatment for glioblastoma, aside from surgical resection and chemoradiation with temozolomide
5. Active systemic infection requiring treatment
6. History of any malignancy (other than glioblastoma) during the last three years except non-melanoma skin cancer, in situ cervical cancer, treated superficial bladder cancer, cured, early-stage prostate cancer in a patient with PSA level less than ULN,or other carcinoma in situ that has been adequately treated and cured.
7. Planned major surgery
8. Evidence of current drug or alcohol abuse
9. Known allergy or hypersensitivity to keyhole limpet hemocyanin (KLH), GM-CSF (sargramostim; LEUKINE®), polysorbate 80 or yeast derived products, or a history of anaphylactic reactions to shellfish proteins
10. Severe acute or chronic medical or psychiatric condition or laboratory abnormality that could increase the risk associated with participating in a clinical trial
11. Women who are pregnant or lactating
Query!
Study design
Purpose of the study
Treatment
Query!
Allocation to intervention
Randomised controlled trial
Query!
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Query!
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Query!
Masking / blinding
Blinded (masking used)
Query!
Who is / are masked / blinded?
The people receiving the treatment/s
The people administering the treatment/s
The people analysing the results/data
Query!
Query!
Query!
Query!
Intervention assignment
Parallel
Query!
Other design features
Query!
Phase
Phase 3
Query!
Type of endpoint/s
Query!
Statistical methods / analysis
Query!
Recruitment
Recruitment status
Completed
Query!
Data analysis
Query!
Reason for early stopping/withdrawal
Query!
Other reasons
Query!
Date of first participant enrolment
Anticipated
Query!
Actual
1/11/2011
Query!
Date of last participant enrolment
Anticipated
Query!
Actual
Query!
Date of last data collection
Anticipated
Query!
Actual
1/11/2016
Query!
Sample size
Target
Query!
Accrual to date
Query!
Final
745
Query!
Recruitment in Australia
Recruitment state(s)
NSW,QLD,SA,TAS,VIC,WA
Query!
Recruitment hospital [1]
0
0
Prince of Wales Hospital - Randwick
Query!
Recruitment hospital [2]
0
0
Royal North Shore Hospital - St Leonards
Query!
Recruitment hospital [3]
0
0
The Crown Princess Mary Cancer Centre, Westmead Hospital - Westmead
Query!
Recruitment hospital [4]
0
0
Royal Brisbane and Women's Hospital - Herston
Query!
Recruitment hospital [5]
0
0
Mater Adult Hospital, Mater Misericordiae Health Services Brisbane Limited - South Brisbane
Query!
Recruitment hospital [6]
0
0
Royal Adelaide Hospital - Adelaide
Query!
Recruitment hospital [7]
0
0
Calvary North Adelaide Hospital - North Adelaide
Query!
Recruitment hospital [8]
0
0
Royal Hobart Hospital - Hobart
Query!
Recruitment hospital [9]
0
0
Launceston General Hospital - Launceston
Query!
Recruitment hospital [10]
0
0
Monash Medical Centre - Clayton
Query!
Recruitment hospital [11]
0
0
Austin Health - Heidelberg
Query!
Recruitment hospital [12]
0
0
Epworth Healthcare - Richmond
Query!
Recruitment hospital [13]
0
0
Sir Charles Gairdner Hospital - Nedlands
Query!
Recruitment hospital [14]
0
0
Liverpool Hospital - Liverpool
Query!
Recruitment postcode(s) [1]
0
0
2031 - Randwick
Query!
Recruitment postcode(s) [2]
0
0
2605 - St Leonards
Query!
Recruitment postcode(s) [3]
0
0
2145 - Westmead
Query!
Recruitment postcode(s) [4]
0
0
4029 - Herston
Query!
Recruitment postcode(s) [5]
0
0
4101 - South Brisbane
Query!
Recruitment postcode(s) [6]
0
0
5000 - Adelaide
Query!
Recruitment postcode(s) [7]
0
0
5006 - North Adelaide
Query!
Recruitment postcode(s) [8]
0
0
7000 - Hobart
Query!
Recruitment postcode(s) [9]
0
0
7250 - Launceston
Query!
Recruitment postcode(s) [10]
0
0
3199 - Clayton
Query!
Recruitment postcode(s) [11]
0
0
3084 - Heidelberg
Query!
Recruitment postcode(s) [12]
0
0
3121 - Richmond
Query!
Recruitment postcode(s) [13]
0
0
06008 - Nedlands
Query!
Recruitment postcode(s) [14]
0
0
2107 - Liverpool
Query!
Recruitment outside Australia
Country [1]
0
0
United States of America
Query!
State/province [1]
0
0
Alabama
Query!
Country [2]
0
0
United States of America
Query!
State/province [2]
0
0
Arizona
Query!
Country [3]
0
0
United States of America
Query!
State/province [3]
0
0
Arkansas
Query!
Country [4]
0
0
United States of America
Query!
State/province [4]
0
0
California
Query!
Country [5]
0
0
United States of America
Query!
State/province [5]
0
0
Connecticut
Query!
Country [6]
0
0
United States of America
Query!
State/province [6]
0
0
Delaware
Query!
Country [7]
0
0
United States of America
Query!
State/province [7]
0
0
Florida
Query!
Country [8]
0
0
United States of America
Query!
State/province [8]
0
0
Georgia
Query!
Country [9]
0
0
United States of America
Query!
State/province [9]
0
0
Hawaii
Query!
Country [10]
0
0
United States of America
Query!
State/province [10]
0
0
Illinois
Query!
Country [11]
0
0
United States of America
Query!
State/province [11]
0
0
Iowa
Query!
Country [12]
0
0
United States of America
Query!
State/province [12]
0
0
Kentucky
Query!
Country [13]
0
0
United States of America
Query!
State/province [13]
0
0
Louisiana
Query!
Country [14]
0
0
United States of America
Query!
State/province [14]
0
0
Maryland
Query!
Country [15]
0
0
United States of America
Query!
State/province [15]
0
0
Massachusetts
Query!
Country [16]
0
0
United States of America
Query!
State/province [16]
0
0
Michigan
Query!
Country [17]
0
0
United States of America
Query!
State/province [17]
0
0
Minnesota
Query!
Country [18]
0
0
United States of America
Query!
State/province [18]
0
0
Missouri
Query!
Country [19]
0
0
United States of America
Query!
State/province [19]
0
0
Nebraska
Query!
Country [20]
0
0
United States of America
Query!
State/province [20]
0
0
New Hampshire
Query!
Country [21]
0
0
United States of America
Query!
State/province [21]
0
0
New Jersey
Query!
Country [22]
0
0
United States of America
Query!
State/province [22]
0
0
New York
Query!
Country [23]
0
0
United States of America
Query!
State/province [23]
0
0
North Carolina
Query!
Country [24]
0
0
United States of America
Query!
State/province [24]
0
0
Ohio
Query!
Country [25]
0
0
United States of America
Query!
State/province [25]
0
0
Oregon
Query!
Country [26]
0
0
United States of America
Query!
State/province [26]
0
0
Pennsylvania
Query!
Country [27]
0
0
United States of America
Query!
State/province [27]
0
0
South Carolina
Query!
Country [28]
0
0
United States of America
Query!
State/province [28]
0
0
Tennessee
Query!
Country [29]
0
0
United States of America
Query!
State/province [29]
0
0
Texas
Query!
Country [30]
0
0
United States of America
Query!
State/province [30]
0
0
Utah
Query!
Country [31]
0
0
United States of America
Query!
State/province [31]
0
0
Vermont
Query!
Country [32]
0
0
United States of America
Query!
State/province [32]
0
0
Virginia
Query!
Country [33]
0
0
United States of America
Query!
State/province [33]
0
0
Washington
Query!
Country [34]
0
0
United States of America
Query!
State/province [34]
0
0
Wisconsin
Query!
Country [35]
0
0
Austria
Query!
State/province [35]
0
0
Innsbruck
Query!
Country [36]
0
0
Austria
Query!
State/province [36]
0
0
Vienna
Query!
Country [37]
0
0
Belgium
Query!
State/province [37]
0
0
Antwerp
Query!
Country [38]
0
0
Belgium
Query!
State/province [38]
0
0
Antwerpen
Query!
Country [39]
0
0
Belgium
Query!
State/province [39]
0
0
Ghent
Query!
Country [40]
0
0
Brazil
Query!
State/province [40]
0
0
Rio Grande Do Sul
Query!
Country [41]
0
0
Brazil
Query!
State/province [41]
0
0
São Paulo
Query!
Country [42]
0
0
Brazil
Query!
State/province [42]
0
0
Rio de Janeiro
Query!
Country [43]
0
0
Brazil
Query!
State/province [43]
0
0
Sao Paulo
Query!
Country [44]
0
0
Canada
Query!
State/province [44]
0
0
Alberta
Query!
Country [45]
0
0
Canada
Query!
State/province [45]
0
0
British Columbia
Query!
Country [46]
0
0
Canada
Query!
State/province [46]
0
0
Manitoba
Query!
Country [47]
0
0
Canada
Query!
State/province [47]
0
0
Nova Scotia
Query!
Country [48]
0
0
Canada
Query!
State/province [48]
0
0
Ontario
Query!
Country [49]
0
0
Canada
Query!
State/province [49]
0
0
Quebec
Query!
Country [50]
0
0
Colombia
Query!
State/province [50]
0
0
Bogota D.C
Query!
Country [51]
0
0
Czechia
Query!
State/province [51]
0
0
Ceske Budejovice
Query!
Country [52]
0
0
Czechia
Query!
State/province [52]
0
0
Prague
Query!
Country [53]
0
0
Czechia
Query!
State/province [53]
0
0
Praha 5
Query!
Country [54]
0
0
Czechia
Query!
State/province [54]
0
0
Usti nad Labem
Query!
Country [55]
0
0
France
Query!
State/province [55]
0
0
Angers
Query!
Country [56]
0
0
France
Query!
State/province [56]
0
0
Bordeaux
Query!
Country [57]
0
0
France
Query!
State/province [57]
0
0
Lyon
Query!
Country [58]
0
0
France
Query!
State/province [58]
0
0
Montpellier
Query!
Country [59]
0
0
France
Query!
State/province [59]
0
0
Nantes
Query!
Country [60]
0
0
France
Query!
State/province [60]
0
0
Paris
Query!
Country [61]
0
0
France
Query!
State/province [61]
0
0
Rennes
Query!
Country [62]
0
0
France
Query!
State/province [62]
0
0
St Herblain
Query!
Country [63]
0
0
France
Query!
State/province [63]
0
0
Villejuif
Query!
Country [64]
0
0
Germany
Query!
State/province [64]
0
0
Bavaria
Query!
Country [65]
0
0
Germany
Query!
State/province [65]
0
0
Erlangen
Query!
Country [66]
0
0
Germany
Query!
State/province [66]
0
0
Frankfurt
Query!
Country [67]
0
0
Germany
Query!
State/province [67]
0
0
Hamburg
Query!
Country [68]
0
0
Germany
Query!
State/province [68]
0
0
Heidelberg
Query!
Country [69]
0
0
Germany
Query!
State/province [69]
0
0
Kiel
Query!
Country [70]
0
0
Germany
Query!
State/province [70]
0
0
Muenster
Query!
Country [71]
0
0
Germany
Query!
State/province [71]
0
0
Munich
Query!
Country [72]
0
0
Greece
Query!
State/province [72]
0
0
Attiki
Query!
Country [73]
0
0
Greece
Query!
State/province [73]
0
0
District Of Attica
Query!
Country [74]
0
0
Hungary
Query!
State/province [74]
0
0
Budapest
Query!
Country [75]
0
0
Hungary
Query!
State/province [75]
0
0
Debrecen
Query!
Country [76]
0
0
Hungary
Query!
State/province [76]
0
0
Miskolc
Query!
Country [77]
0
0
Hungary
Query!
State/province [77]
0
0
Pécs
Query!
Country [78]
0
0
Hungary
Query!
State/province [78]
0
0
Szeged
Query!
Country [79]
0
0
Hungary
Query!
State/province [79]
0
0
Szombathely
Query!
Country [80]
0
0
India
Query!
State/province [80]
0
0
Andhra Pradesh
Query!
Country [81]
0
0
India
Query!
State/province [81]
0
0
Karnataka
Query!
Country [82]
0
0
India
Query!
State/province [82]
0
0
Kerala
Query!
Country [83]
0
0
India
Query!
State/province [83]
0
0
Maharashtra
Query!
Country [84]
0
0
India
Query!
State/province [84]
0
0
Mumbai
Query!
Country [85]
0
0
India
Query!
State/province [85]
0
0
New Delhi
Query!
Country [86]
0
0
India
Query!
State/province [86]
0
0
Pune
Query!
Country [87]
0
0
India
Query!
State/province [87]
0
0
Tamil Nadu
Query!
Country [88]
0
0
India
Query!
State/province [88]
0
0
Delhi
Query!
Country [89]
0
0
Israel
Query!
State/province [89]
0
0
Beer-Sheva
Query!
Country [90]
0
0
Israel
Query!
State/province [90]
0
0
Haifa
Query!
Country [91]
0
0
Israel
Query!
State/province [91]
0
0
Jerusalem
Query!
Country [92]
0
0
Israel
Query!
State/province [92]
0
0
Tel Hashomer
Query!
Country [93]
0
0
Israel
Query!
State/province [93]
0
0
Tel-Aviv
Query!
Country [94]
0
0
Italy
Query!
State/province [94]
0
0
Bologna
Query!
Country [95]
0
0
Italy
Query!
State/province [95]
0
0
Milano
Query!
Country [96]
0
0
Italy
Query!
State/province [96]
0
0
Rome
Query!
Country [97]
0
0
Italy
Query!
State/province [97]
0
0
Torino
Query!
Country [98]
0
0
Mexico
Query!
State/province [98]
0
0
D.F
Query!
Country [99]
0
0
Mexico
Query!
State/province [99]
0
0
Jalisco
Query!
Country [100]
0
0
Mexico
Query!
State/province [100]
0
0
Sinaloa
Query!
Country [101]
0
0
Mexico
Query!
State/province [101]
0
0
Durango
Query!
Country [102]
0
0
Mexico
Query!
State/province [102]
0
0
San Luis Potosí
Query!
Country [103]
0
0
Netherlands
Query!
State/province [103]
0
0
Zuid Holland
Query!
Country [104]
0
0
Netherlands
Query!
State/province [104]
0
0
Amsterdam
Query!
Country [105]
0
0
Netherlands
Query!
State/province [105]
0
0
Nijmegen
Query!
Country [106]
0
0
New Zealand
Query!
State/province [106]
0
0
Christchurch
Query!
Country [107]
0
0
New Zealand
Query!
State/province [107]
0
0
Palmerston North
Query!
Country [108]
0
0
New Zealand
Query!
State/province [108]
0
0
Waikato District
Query!
Country [109]
0
0
New Zealand
Query!
State/province [109]
0
0
Waikato Distric
Query!
Country [110]
0
0
Peru
Query!
State/province [110]
0
0
Chiclayo
Query!
Country [111]
0
0
Peru
Query!
State/province [111]
0
0
Lima
Query!
Country [112]
0
0
Spain
Query!
State/province [112]
0
0
Catalonia
Query!
Country [113]
0
0
Spain
Query!
State/province [113]
0
0
Girona
Query!
Country [114]
0
0
Spain
Query!
State/province [114]
0
0
Barcelona
Query!
Country [115]
0
0
Spain
Query!
State/province [115]
0
0
Barcelonia
Query!
Country [116]
0
0
Spain
Query!
State/province [116]
0
0
Madrid
Query!
Country [117]
0
0
Switzerland
Query!
State/province [117]
0
0
AG
Query!
Country [118]
0
0
Switzerland
Query!
State/province [118]
0
0
VD
Query!
Country [119]
0
0
Switzerland
Query!
State/province [119]
0
0
Bellinzona
Query!
Country [120]
0
0
Switzerland
Query!
State/province [120]
0
0
Bern
Query!
Country [121]
0
0
Switzerland
Query!
State/province [121]
0
0
Geneva
Query!
Country [122]
0
0
Switzerland
Query!
State/province [122]
0
0
Zurich
Query!
Country [123]
0
0
Taiwan
Query!
State/province [123]
0
0
Bei District
Query!
Country [124]
0
0
Taiwan
Query!
State/province [124]
0
0
Kaohsiung
Query!
Country [125]
0
0
Taiwan
Query!
State/province [125]
0
0
Taichung
Query!
Country [126]
0
0
Taiwan
Query!
State/province [126]
0
0
Tainan City - Yongkang District
Query!
Country [127]
0
0
Taiwan
Query!
State/province [127]
0
0
Taipei city - Neihu District
Query!
Country [128]
0
0
Thailand
Query!
State/province [128]
0
0
Bangkok
Query!
Country [129]
0
0
Thailand
Query!
State/province [129]
0
0
Bankok
Query!
Country [130]
0
0
Thailand
Query!
State/province [130]
0
0
Chiang Mai
Query!
Country [131]
0
0
Thailand
Query!
State/province [131]
0
0
Songkla
Query!
Country [132]
0
0
United Kingdom
Query!
State/province [132]
0
0
Surrey
Query!
Country [133]
0
0
United Kingdom
Query!
State/province [133]
0
0
Bristol
Query!
Country [134]
0
0
United Kingdom
Query!
State/province [134]
0
0
Edinburgh
Query!
Country [135]
0
0
United Kingdom
Query!
State/province [135]
0
0
Glasgow
Query!
Country [136]
0
0
United Kingdom
Query!
State/province [136]
0
0
London
Query!
Country [137]
0
0
United Kingdom
Query!
State/province [137]
0
0
Nottingham
Query!
Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Query!
Name
Celldex Therapeutics
Query!
Address
Query!
Country
Query!
Ethics approval
Ethics application status
Query!
Summary
Brief summary
This 2-arm, randomized, phase III study will investigate the efficacy and safety of the addition of rindopepimut (an experimental cancer vaccine that may act to promote anti-cancer effects in patients who have tumors that express the EGFRvIII protein) to the current standard of care (temozolomide) in patients with recently diagnosed glioblastoma, a type of brain cancer. All patients will be administered temozolomide, the standard treatment for glioblastoma. Half the patients will be randomly assigned to receive rindopepimut and half the patients will be randomly assigned to receive a control called keyhole limpet hemocyanin. Patients will be treated in a blinded fashion (neither the patient or the doctor will know which arm of the study the patient is on). Patients will be treated until disease progression or intolerance to therapy and all patients will be followed for survival.
Query!
Trial website
https://clinicaltrials.gov/study/NCT01480479
Query!
Trial related presentations / publications
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hirte H, Ashby L, Mechtler L, Goldlust SA, Iwamoto F, Drappatz J, O'Rourke DM, Wong M, Hamilton MG, Finocchiaro G, Perry J, Wick W, Green J, He Y, Turner CD, Yellin MJ, Keler T, Davis TA, Stupp R, Sampson JH; ACT IV trial investigators. Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial. Lancet Oncol. 2017 Oct;18(10):1373-1385. doi: 10.1016/S1470-2045(17)30517-X. Epub 2017 Aug 23.
Query!
Public notes
Query!
Contacts
Principal investigator
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for public queries
Name
0
0
Query!
Address
0
0
Query!
Country
0
0
Query!
Phone
0
0
Query!
Fax
0
0
Query!
Email
0
0
Query!
Contact person for scientific queries
No information has been provided regarding IPD availability
What supporting documents are/will be available?
No Supporting Document Provided
Results publications and other study-related documents
Type
Citations or Other Details
Journal
Weller M, Butowski N, Tran DD, Recht LD, Lim M, Hi...
[
More Details
]
Results not provided in
https://clinicaltrials.gov/study/NCT01480479
Download to PDF